Blockade of the estrogen receptor alpha–pregnane X receptor axis protects ovariectomized mice against ethanol-induced hepatotoxicity
Women develop alcohol-associated liver disease (ALD) faster than men at any level of alcohol consumption, implicating estrogen as a contributing factor. However, the precise mechanism remains unknown. Therefore, 12-week-old female C57BL/6N mice were subjected to either bilateral ovariectomy (OVX) or sham surgery. After a 3-week recovery period, the mice were fed either a 5% ethanol (EtOH)-containing liquid diet or paired-fed control diet for 10 days followed by a single gavage dose of EtOH (5 g/kg, 30% EtOH solution). The mice were examined for serum biochemical parameters, hepatotoxicity, histology, expression of xenobiotic nuclear receptors, pregnane X receptor (PXR) and constitutive androstane receptor, and their target gene mRNAs and proteins in hepatic and perigonadal white adipose tissues (pgWATs). While OVX mice on a control diet significantly gained weight, EtOH significantly increased hepatotoxicity, residual EtOH levels, lipid peroxidation, and oxidative stress in sham-operated mice but not in their OVX counterparts. In addition, in the livers and pgWAT of the sham mice, EtOH significantly increased the mRNA and/or protein levels of the major estrogen receptor (estrogen receptor α), PXR, constitutive androstane receptor, and their target genes, proinflammatory cytokines and chemokines, lipogenic genes, and fibroblast growth factor 21 levels, a predictive biomarker for ALD severity in humans, but inhibited nuclear factor erythroid 2-related factor 2 (NRF2) and its target genes encoding NQO1 and BHMT (betaine-homocysteine S-methyltransferase). Unexpectedly, all these changes were attenuated in the EtOH-fed OVX mice by the upregulation of NRF2 and aryl hydrocarbon receptor and their downstream antioxidant target genes. Together, these results suggest the existence of an estrogen-regulated estrogen receptor α-PXR-NRF2 signaling axis in liver and pgWAT, which contributes to sexual dimorphism in ALD.
Authors
- Malvin Ofosu‐Boateng (ORCID: https://orcid.org/0000-0002-1407-1876)
- Daniel Okwudili Nnamani (ORCID: https://orcid.org/0000-0002-6788-3835)
- Kusum K. Kharbanda (ORCID: https://orcid.org/0000-0001-7759-8889)
- Nour Yadak
- Maxwell A. Gyamfi (ORCID: https://orcid.org/0009-0005-8403-9467)
- Lidya H Gebreyesus (ORCID: https://orcid.org/0000-0002-5540-637X)
- Frank J. Gonzalez (ORCID: https://orcid.org/0000-0002-7990-2140)
- Elizabeth Twum
Institutions
- Nebraska Medical Center (US)
- University of Tennessee Health Science Center (US)
- National Cancer Institute (US)
- Center for Cancer Research (US)
- University of Nebraska Medical Center (US)
Publication Details
- Journal
- Journal of Biological Chemistry
- Published
- 2025-05-15
- DOI
- https://doi.org/10.1016/j.jbc.2025.110238
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Veterans Affairs
- Biomedical Laboratory Research and Development, VA Office of Research and Development
- National Institutes of Health
- Health Science Center, University of Tennessee
- National Institute on Alcohol Abuse and Alcoholism
- National Cancer Institute